Press release

New MRI portfolio from Siemens Healthineers expands the reach of BioMatrix Technology

Published on November 25, 2018

Magnetom Lumina is 510(k) pending. It is not for sale in the U.S. Its future availability cannot be guaranteed.

Magnetom Amira – A BioMatrix System is 510(k) pending. It is not for sale in the U.S. Its future availability cannot be guaranteed.

Cardiac Triggering is still under development and not commercially available yet. Its future availability cannot be ensured.

The motion correction framework is 510(k) pending. It is not commercially available in all countries. Due to regulatory reasons the future availability cannot be guaranteed.

SMS RESOLVE, CS ToF, CS SPACE, CS SEMAC are pending 510 (k) clearances, and are not yet commercially available in the U.S. Its future availability cannot be guaranteed.

The in-bore Infotainment system InnovisionTM is still under development and not yet commercially available. Its future availability cannot be guaranteed.

Siemens Healthineers 2018

Siemens Healthineers enables healthcare providers worldwide to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, improving patient experience and digitalizing healthcare. A leader in medical technology, Siemens Healthineers is constantly innovating its portfolio of products and services in its core areas of diagnostic and therapeutic imaging and in laboratory diagnostics and molecular medicine. Siemens Healthineers is also actively developing its digital health services and enterprise services. In fiscal 2018, which ended on September 30, 2018, Siemens Healthineers generated revenue of €13.4 billion and adjusted profit of €2.3 billion and has about 50,000 employees worldwide.